Luis E. Raez, MD, discusses the current liquid biopsy options for patients with lung cancer through assessing circulating tumor DNA. Luis E. Raez, MD, medical director and chief scientific officer at ...

so liquid biopsy has made a huge difference. A lot of times when you don't have enough tissue or you can't run the test, that's a huge opportunity. Can you talk through some of the challenges both ...

You’ve discovered some interesting biology and have a set of required parameters, thousands of data points, a budget and a deadline. How can you harness the power of computational chemistry to ...

In a paper recently published in the journal Acta Neuropathologica Communications, DetermaCNI showed promise as a liquid biopsy method for diagnosing and profiling central nervous system tumors by ...

A stomach biopsy allows your healthcare provider to examine tissues under a microscope. This can help your provider diagnose conditions that affect your stomach and digestive tract. More formally ...

Recently, advances in minimally-invasive liquid biopsy techniques and biomarkers such as circulating tumor DNA (ctDNA) have demonstrated potential to transform the field of cancer care by aiding ...

A biopsy of the eye is a test where your eye specialist (ophthalmologist) takes a sample (biopsy) of fluid or tissue from your eye. Your specialist might take a biopsy from your eye to check for ...

Liquid biopsy is an innovative new technology that tests cancer cells circulating in your bloodstream. It is not as sensitive a test as tumor-based next-generation sequencing (NGS) but it can be ...

French Liquid Biopsy Program Delivering Personalized Care November 29, 2024 A novel program to bring liquid biopsies into clinical care for patients with advanced cancer has been launched in France.